Inhibitors of tyk2
US-2024425484-A1 · Dec 26, 2024 · US
Cyclic amine substituted pyrimidinediamines as PKC inhibitors
US8993585B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8993585-B2 |
| Application number | US-17544108-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 17, 2008 |
| Priority date | Jul 17, 2007 |
| Publication date | Mar 31, 2015 |
| Grant date | Mar 31, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The invention encompasses compounds having formula I or II and the compositions and methods using these compounds in the treatment of conditions in which inhibition of PKC and PKD is therapeutically useful.
First claim
Opening claim text (preview).
We claim: 1. A compound of formula I: N-oxide, or therapeutically acceptable salt thereof; wherein: X is selected from alkyl, substituted alkyl, hydroxy, alkoxy, substituted alkoxy, amino, substituted amino, aminocarbonyl, carboxyl, carboxyl ester, cyano, fluoro, chloro, nitro, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, and trihalomethyl; R 1…
Assignees
Inventors
Classifications
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8993585B2 cover?
- The invention encompasses compounds having formula I or II and the compositions and methods using these compounds in the treatment of conditions in which inhibition of PKC and PKD is therapeutically useful.
- Who is the assignee on this patent?
- Singh Rajinder, Li Hui, Zhao Haoran, and 6 more
- What technology area does this patent fall under?
- Primary CPC classification C07D401/12. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Mar 31 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).